These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19778569)

  • 1. Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
    Zai CC; Tiwari AK; Basile V; de Luca V; Müller DJ; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):50-6. PubMed ID: 19778569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia.
    Pae CU
    Psychiatry Res; 2008 Dec; 161(3):336-8. PubMed ID: 18977034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].
    Gałecki P; Pietras T; Szemraj J
    Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia.
    Pae CU; Kim TS; Patkar AA; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
    Psychiatry Res; 2007 Sep; 153(1):77-81. PubMed ID: 17582511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer.
    Olson SH; Carlson MD; Ostrer H; Harlap S; Stone A; Winters M; Ambrosone CB
    Gynecol Oncol; 2004 Jun; 93(3):615-20. PubMed ID: 15196853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide dismutase and nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase polymorphisms and pancreatic cancer risk.
    Mohelnikova-Duchonova B; Marsakova L; Vrana D; Holcatova I; Ryska M; Smerhovsky Z; Slamova A; Schejbalova M; Soucek P
    Pancreas; 2011 Jan; 40(1):72-8. PubMed ID: 20966810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between a functional NAD(P)H: quinone oxidoreductase gene polymorphism (Pro187Ser) and tardive dyskinesia.
    Hori H; Shinkai T; Matsumoto C; Ohmori O; Nakamura J
    Neuromolecular Med; 2006; 8(3):375-80. PubMed ID: 16775388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease.
    Fong CS; Wu RM; Shieh JC; Chao YT; Fu YP; Kuao CL; Cheng CW
    Clin Chim Acta; 2007 Mar; 378(1-2):136-41. PubMed ID: 17188257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
    Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia.
    Pae CU; Yu HS; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):495-500. PubMed ID: 15151706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.
    Hitzeroth A; Niehaus DJ; Koen L; Botes WC; Deleuze JF; Warnich L
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):664-72. PubMed ID: 17291655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Gelatti U; Placidi D; Carta A; Hautefeuille A; Porru S
    Carcinogenesis; 2004 Jun; 25(6):973-8. PubMed ID: 14729580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia.
    Zai CC; Tiwari AK; De Luca V; Müller DJ; Bulgin N; Hwang R; Zai GC; King N; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Kennedy JL
    Eur Neuropsychopharmacol; 2009 May; 19(5):317-28. PubMed ID: 19217756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and tardive dyskinesia: pharmacogenetic evidence.
    Cho CH; Lee HJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():207-13. PubMed ID: 23123399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients.
    Kang SG; Choi JE; An H; Park YM; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Joe SH; Jung IK; Kim L; Lee MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1844-7. PubMed ID: 18790709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between Ala9Val functional polymorphism of MnSOD gene and schizophrenia in a representative Italian sample.
    Ventriglia M; Scassellati C; Bonvicini C; Squitti R; Bevacqua MG; Foresti G; Tura GB; Gennarelli M
    Neurosci Lett; 2006 Dec; 410(3):208-11. PubMed ID: 17055157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of tardive dyskinesia.
    Lee HJ; Kang SG
    Int Rev Neurobiol; 2011; 98():231-64. PubMed ID: 21907090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of NAD(P)H:quinone oxidoreductase 1 and superoxide dismutase polymorphisms in ulcerative colitis.
    Kosaka T; Yoshino J; Inui K; Wakabayashi T; Kobayashi T; Watanabe S; Hayashi S; Hirokawa Y; Shiraishi T; Yamamoto T; Tsuji M; Katoh T; Watanabe M
    DNA Cell Biol; 2009 Dec; 28(12):625-31. PubMed ID: 19715479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristics of human mammary tumors.
    Hubackova M; Vaclavikova R; Mrhalova M; Kubackova K; Kodet R; Gut I; Soucek P
    Pharmacogenet Genomics; 2009 Jul; 19(7):505-12. PubMed ID: 19494791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.